HIV-1 Drug Resistance in the iPrEx Preexposure Prophylaxis Trial

Background. The iPrEx study demonstrated that combination oral emtricitabine and tenofovir disoproxil fumarate (FTC/TDF) as preexposure prophylaxis (PrEP) protects against HIV acquisition in men who have sex with men and transgender women. Selection for drug resistance could offset PrEP benefits. Me...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Liegler, Teri, Abdel-Mohsen, Mohamed, Bentley, L. Gordon, Atchison, Robert, Schmidt, Timothy, Javier, Jacqueline, Mehrotra, Megha, Eden, Christopher, Glidden, David V., McMahan, Vanessa, Anderson, Peter L., Li, Peilin, Wong, Joseph K., Buchbinder, Susan, Guanira, Juan V., Grant, Robert M.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2014
Assuntos:
Major Articles and Brief Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4176446/
https://ncbi.nlm.nih.gov/pubmed/24740633
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiu233
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados